Hamilton Thorne Ltd
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, inc… Read more
Hamilton Thorne Ltd (HTLZF) - Net Assets
Latest net assets as of September 2024: $65.32 Million USD
Based on the latest financial reports, Hamilton Thorne Ltd (HTLZF) has net assets worth $65.32 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($108.72 Million) and total liabilities ($43.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $65.32 Million |
| % of Total Assets | 60.08% |
| Annual Growth Rate | 25.87% |
| 5-Year Change | 66.87% |
| 10-Year Change | N/A |
| Growth Volatility | 230.1 |
Hamilton Thorne Ltd - Net Assets Trend (2007–2023)
This chart illustrates how Hamilton Thorne Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hamilton Thorne Ltd (2007–2023)
The table below shows the annual net assets of Hamilton Thorne Ltd from 2007 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $64.65 Million | +15.04% |
| 2022-12-31 | $56.20 Million | +0.43% |
| 2021-12-31 | $55.96 Million | +9.58% |
| 2020-12-31 | $51.07 Million | +31.81% |
| 2019-12-31 | $38.74 Million | +16.85% |
| 2018-12-31 | $33.16 Million | +52.94% |
| 2017-12-31 | $21.68 Million | +536.99% |
| 2016-12-31 | $3.40 Million | +108.36% |
| 2015-12-31 | $1.63 Million | +191.50% |
| 2014-12-31 | $-1.79 Million | +46.65% |
| 2013-12-31 | $-3.35 Million | +6.23% |
| 2012-12-31 | $-3.57 Million | -29.89% |
| 2011-12-31 | $-2.75 Million | +48.47% |
| 2010-12-31 | $-5.33 Million | -43.08% |
| 2009-12-31 | $-3.73 Million | -479.34% |
| 2008-12-31 | $982.26K | -39.72% |
| 2007-12-31 | $1.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hamilton Thorne Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1730654800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $74.02 Million | 114.49% |
| Other Comprehensive Income | $-1.32 Million | -2.04% |
| Other Components | $9.26 Million | 14.32% |
| Total Equity | $64.65 Million | 100.00% |
Hamilton Thorne Ltd Competitors by Market Cap
The table below lists competitors of Hamilton Thorne Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rukun Raharja Tbk
JK:RAJA
|
$180.68 Million |
|
Goody Science & Technology Co Ltd
SHE:002694
|
$180.71 Million |
|
ScinoPharm Taiwan Ltd
TW:1789
|
$180.77 Million |
|
Fibra Inn
MX:FINN13
|
$180.78 Million |
|
Neo Performance Materials Inc
PINK:NOPMF
|
$180.66 Million |
|
ButOne Information Corp XiAn
SHG:600455
|
$180.66 Million |
|
Graf Global Corp
NYSE MKT:GRAF
|
$180.65 Million |
|
Shanghai No1 Pharmacy Co Ltd
SHG:600833
|
$180.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hamilton Thorne Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 56,196,671 to 64,651,380, a change of 8,454,709 (15.0%).
- Net loss of 607,022 reduced equity.
- Other comprehensive income increased equity by 1,723,653.
- Other factors increased equity by 7,338,078.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-607.02K | -0.94% |
| Other Comprehensive Income | $1.72 Million | +2.67% |
| Other Changes | $7.34 Million | +11.35% |
| Total Change | $- | 15.04% |
Book Value vs Market Value Analysis
This analysis compares Hamilton Thorne Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.60x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.41x to 3.60x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $1.12 | $1.58 | x |
| 2008-12-31 | $0.31 | $1.58 | x |
| 2009-12-31 | $-0.21 | $1.58 | x |
| 2010-12-31 | $-0.22 | $1.58 | x |
| 2011-12-31 | $-0.09 | $1.58 | x |
| 2012-12-31 | $-0.07 | $1.58 | x |
| 2013-12-31 | $-0.06 | $1.58 | x |
| 2014-12-31 | $-0.03 | $1.58 | x |
| 2015-12-31 | $0.02 | $1.58 | x |
| 2016-12-31 | $0.05 | $1.58 | x |
| 2017-12-31 | $0.20 | $1.58 | x |
| 2018-12-31 | $0.26 | $1.58 | x |
| 2019-12-31 | $0.29 | $1.58 | x |
| 2020-12-31 | $0.37 | $1.58 | x |
| 2021-12-31 | $0.38 | $1.58 | x |
| 2022-12-31 | $0.38 | $1.58 | x |
| 2023-12-31 | $0.44 | $1.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hamilton Thorne Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.94%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.90%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.69x
- Recent ROE (-0.94%) is below the historical average (4.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | -13.44% | -643.62% | 0.02x | 1.01x | $-382.00K |
| 2008 | -35.03% | -1391.30% | 0.02x | 1.04x | $-442.36K |
| 2009 | 0.00% | -34.93% | 1.82x | 0.00x | $-1.30 Million |
| 2010 | 0.00% | -29.73% | 2.45x | 0.00x | $-1.31 Million |
| 2011 | 0.00% | -26.42% | 2.64x | 0.00x | $-1.62 Million |
| 2012 | 0.00% | -25.90% | 3.09x | 0.00x | $-1.28 Million |
| 2013 | 0.00% | 1.67% | 3.56x | 0.00x | $459.78K |
| 2014 | 0.00% | 9.83% | 2.41x | 0.00x | $1.03 Million |
| 2015 | 62.91% | 11.37% | 1.27x | 4.35x | $864.19K |
| 2016 | 19.95% | 6.46% | 0.86x | 3.60x | $338.61K |
| 2017 | 26.32% | 25.80% | 0.59x | 1.74x | $3.54 Million |
| 2018 | 8.93% | 10.13% | 0.61x | 1.43x | $-355.25K |
| 2019 | 2.05% | 2.24% | 0.61x | 1.50x | $-3.08 Million |
| 2020 | 1.90% | 2.44% | 0.57x | 1.37x | $-4.14 Million |
| 2021 | 4.35% | 4.65% | 0.70x | 1.34x | $-3.16 Million |
| 2022 | 3.40% | 3.42% | 0.64x | 1.56x | $-3.71 Million |
| 2023 | -0.94% | -0.90% | 0.62x | 1.69x | $-7.07 Million |
Industry Comparison
This section compares Hamilton Thorne Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hamilton Thorne Ltd (HTLZF) | $65.32 Million | -13.44% | 0.66x | $180.66 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |